Hollsteen
← Micron

Equity incl. NCI

Balance – as of period end · $B

QuartersFiscal years

$BEquity incl. NCI · Q1 FY2016: $13.3B · 10-Q 0000723125-16-000146 filed Jan 8, 2016Equity incl. NCI · Q2 FY2016: $13.2B · 10-Q 0000723125-16-000176 filed Apr 8, 2016Equity incl. NCI · Q3 FY2016: $13.0B · 10-Q 0000723125-16-000201 filed Jul 6, 2016Equity incl. NCI · Q4 FY2016: $12.9B · 10-K 0000723125-16-000269 filed Oct 28, 2016Equity incl. NCI · Q1 FY2017: $13.2B · 10-Q 0000723125-17-000005 filed Jan 9, 2017Equity incl. NCI · Q2 FY2017: $15.1B · 10-Q 0000723125-17-000037 filed Mar 28, 2017Equity incl. NCI · Q3 FY2017: $17.0B · 10-Q 0000723125-17-000085 filed Jun 30, 2017Equity incl. NCI · Q4 FY2017: $19.5B · 10-K 0000723125-17-000131 filed Oct 26, 2017Equity incl. NCI · Q1 FY2018: $23.4B · 10-Q 0000723125-17-000166 filed Dec 20, 2017Equity incl. NCI · Q2 FY2018: $26.6B · 10-Q 0000723125-18-000036 filed Mar 23, 2018Equity incl. NCI · Q3 FY2018: $29.5B · 10-Q 0000723125-18-000065 filed Jun 22, 2018Equity incl. NCI · Q4 FY2018: $33.2B · 10-K 0000723125-18-000092 filed Oct 15, 2018Equity incl. NCI · Q1 FY2019: $34.7B · 10-Q 0000723125-18-000156 filed Dec 19, 2018Equity incl. NCI · Q2 FY2019: $35.4B · 10-Q 0000723125-19-000014 filed Mar 21, 2019Equity incl. NCI · Q3 FY2019: $36.2B · 10-Q 0000723125-19-000035 filed Jun 26, 2019Equity incl. NCI · Q4 FY2019: $36.8B · 10-K 0000723125-19-000094 filed Oct 17, 2019Equity incl. NCI · Q1 FY2020: $36.5B · 10-Q 0000723125-19-000174 filed Dec 20, 2019Equity incl. NCI · Q2 FY2020: $37.0B · 10-Q 0000723125-20-000034 filed Mar 26, 2020Equity incl. NCI · Q3 FY2020: $37.8B · 10-Q 0000723125-20-000067 filed Jun 29, 2020Equity incl. NCI · Q4 FY2020: $39.0B · 10-K 0000723125-20-000082 filed Oct 19, 2020Equity incl. NCI · Q1 FY2021: $39.9B · 10-Q 0000723125-21-000012 filed Jan 8, 2021Equity incl. NCI · Q2 FY2021: $40.7B · 10-Q 0000723125-21-000032 filed Apr 1, 2021Equity incl. NCI · Q3 FY2021: $42.3B · 10-Q 0000723125-21-000052 filed Jul 1, 2021Equity incl. NCI · Q4 FY2021: $43.9B · 10-K 0000723125-21-000065 filed Oct 8, 2021Equity incl. NCI · Q1 FY2022: $45.9B · 10-Q 0000723125-22-000004 filed Jan 6, 2022Equity incl. NCI · Q2 FY2022: $47.8B · 10-Q 0000723125-22-000016 filed Mar 30, 2022Equity incl. NCI · Q3 FY2022: $49.3B · 10-Q 0000723125-22-000036 filed Jul 1, 2022Equity incl. NCI · Q4 FY2022: $49.9B · 10-K 0000723125-22-000048 filed Oct 7, 2022Equity incl. NCI · Q1 FY2023: $49.3B · 10-Q 0000723125-22-000072 filed Dec 22, 2022Equity incl. NCI · Q2 FY2023: $47.3B · 10-Q 0000723125-23-000022 filed Mar 29, 2023Equity incl. NCI · Q3 FY2023: $45.4B · 10-Q 0000723125-23-000041 filed Jun 29, 2023Equity incl. NCI · Q4 FY2023: $44.1B · 10-K 0000723125-23-000054 filed Oct 6, 2023Equity incl. NCI · Q1 FY2024: $42.9B · 10-Q 0000723125-23-000077 filed Dec 21, 2023Equity incl. NCI · Q2 FY2024: $43.9B · 10-Q 0000723125-24-000007 filed Mar 21, 2024Equity incl. NCI · Q3 FY2024: $44.2B · 10-Q 0000723125-24-000019 filed Jun 27, 2024Equity incl. NCI · Q4 FY2024: $45.1B · 10-K 0000723125-24-000027 filed Oct 4, 2024Equity incl. NCI · Q1 FY2025: $46.8B · 10-Q 0000723125-24-000047 filed Dec 19, 2024Equity incl. NCI · Q2 FY2025: $48.6B · 10-Q 0000723125-25-000009 filed Mar 21, 2025Equity incl. NCI · Q3 FY2025: $50.7B · 10-Q 0000723125-25-000021 filed Jun 26, 2025Equity incl. NCI · Q4 FY2025: $54.2B · 10-K 0000723125-25-000028 filed Oct 3, 2025Equity incl. NCI · Q1 FY2026: $58.8B · 10-Q 0000723125-25-000046 filed Dec 18, 2025Equity incl. NCI · Q2 FY2026: $72.5B · 10-Q 0000723125-26-000006 filed Mar 19, 2026Equity incl. NCI · Q3 FY2026: $100.7B · 10-Q 0000723125-26-000015 filed Jun 25, 202650.7100.713.3Q1 FY2016Q3 FY2026
$BEquity incl. NCI · Q4 FY2024: $45.1B · 10-K 0000723125-24-000027 filed Oct 4, 2024Equity incl. NCI · Q1 FY2025: $46.8B · 10-Q 0000723125-24-000047 filed Dec 19, 2024Equity incl. NCI · Q2 FY2025: $48.6B · 10-Q 0000723125-25-000009 filed Mar 21, 2025Equity incl. NCI · Q3 FY2025: $50.7B · 10-Q 0000723125-25-000021 filed Jun 26, 2025Equity incl. NCI · Q4 FY2025: $54.2B · 10-K 0000723125-25-000028 filed Oct 3, 2025Equity incl. NCI · Q1 FY2026: $58.8B · 10-Q 0000723125-25-000046 filed Dec 18, 2025Equity incl. NCI · Q2 FY2026: $72.5B · 10-Q 0000723125-26-000006 filed Mar 19, 2026Equity incl. NCI · Q3 FY2026: $100.7B · 10-Q 0000723125-26-000015 filed Jun 25, 202650.7100.745.1Q4 FY2024Q3 FY2026Q3 FY2025
Q3 FY2025
50.7$B
All values (43)
PeriodValue ($B)Status
Q3 FY2026100.7reported
Q2 FY202672.5reported
Q1 FY202658.8reported
Q4 FY202554.2reported
Q3 FY202550.7reported
Q2 FY202548.6reported
Q1 FY202546.8reported
Q4 FY202445.1reported
Q3 FY202444.2reported
Q2 FY202443.9reported
Q1 FY202442.9reported
Q4 FY202344.1reported
Q3 FY202345.4reported
Q2 FY202347.3reported
Q1 FY202349.3reported
Q4 FY202249.9reported
Q3 FY202249.3reported
Q2 FY202247.8reported
Q1 FY202245.9reported
Q4 FY202143.9reported
Q3 FY202142.3reported
Q2 FY202140.7reported
Q1 FY202139.9reported
Q4 FY202039.0reported
Q3 FY202037.8reported
Q2 FY202037.0reported
Q1 FY202036.5reported
Q4 FY201936.8reported
Q3 FY201936.2reported
Q2 FY201935.4reported
Q1 FY201934.7reported
Q4 FY201833.2reported
Q3 FY201829.5reported
Q2 FY201826.6reported
Q1 FY201823.4reported
Q4 FY201719.5reported
Q3 FY201717.0reported
Q2 FY201715.1reported
Q1 FY201713.2reported
Q4 FY201612.9reported
Q3 FY201613.0reported
Q2 FY201613.2reported
Q1 FY201613.3reported

CSV with all sources · Technical ID: equity_total

More metrics for Micron

Value drivers

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Sources & calculation
Value
$50.7B
Period
Q3 FY2025, ended May 29, 2025 · as of May 29, 2025 (balance as of date, not a sum)
Source
10-Q, filed Jun 26, 2025 · 0000723125-25-000021
Location
us-gaap:StockholdersEquity
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$50.7BJun 26, 202510-Q 0000723125-25-000021reported · confidence 1. · current